This symposium takes a critical look at the ethics of impact on “bystanders” to clinical research. By that we mean study non-participants who nevertheless are at risk of being affected by the study in some way. This introduction suggests some questions to consider while reading through the symposium contributions, and gives a précis of each.
GarnerSARennieSAnanworanichJ, et al. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations. J Virus Erad2017; 3(2): 82–84.
3.
BattinMPFrancisLPJacobsonJA, et al. The ethics of research in infectious disease: experimenting on this patient, risking harm to that one. In: BattinMPFrancisLPJacobsonJA, et al. (eds) The patient as victim and vector: ethics and infectious disease. Oxford: Oxford University Press, 2009.
4.
ChamberlainATLaveryJVWhiteA, et al. Ethics of maternal vaccination. Science2017; 358(6362): 452–453.
5.
GibneyE.Ethics of Internet research trigger scrutiny. Nature2017; 550: 16–17.
6.
CohenJ.Studies that intentionally infect people with disease-causing bugs are on the rise. Science2016. DOI: 10.1126/science.aaf5726.
SnellerMCJustementJSGittensKR, et al. A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Sci Transl Med2017; 9(419): eaan8848.
9.
Committee on Issues in Organ Donor Intervention Research, ChildressJFDomnitzSLivermanCT (eds). Opportunities for organ donor intervention research: saving lives by improving the quality and quantity of organs for transplantation (Consensus Study Report, 10October2017). Washington, DC: The National Academies of Sciences, Engineering, and Medicine, 2017.
